Apart from the public sale, the business intends to make a private placement of $17 million worth of shares to Wellington Hadley Harbor Aggregator IV, an 11% Beta Bonics equity holder. The conclusion ...

The community living unit provides critical services for individuals with intellectual and developmental disabilities and behavioral conditions.

Accolade Inc (ACCD) stock saw a modest uptick, ending the day at $6.89 which represents a slight increase of $0.01 or 0.15% from the prior close of $6.88. The stock opened at $6.87 and touched a low ...

Schrodinger Inc (SDGR) stock saw a modest uptick, ending the day at $24.34 which represents a slight increase of $3.01 or 14.11% from the prior close of $21.33. The stock opened at $21.52 and touched ...

Analysts at Leerink Partnrs lifted their FY2026 earnings estimates for Travere Therapeutics in a research report issued to ...

Leerink Partnrs lifted their FY2024 EPS estimates for Castle Biosciences in a note issued to investors on Tuesday, January ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering.

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...